Current Rheumatology Reports

, Volume 4, Issue 2, pp 165–169

Reflex sympathetic dystrophy

Authors

  • Robert J. Schwartzman
    • Department of NeurologyMCP Hahnemann University School of Medicine
  • Anca Popescu
    • Department of NeurologyMCP Hahnemann University School of Medicine
Article

DOI: 10.1007/s11926-002-0012-2

Cite this article as:
Schwartzman, R.J. & Popescu, A. Curr Rheumatol Rep (2002) 4: 165. doi:10.1007/s11926-002-0012-2

Abstract

Reflex sympathetic dystrophy (RSD) is composed of five major features: pain, swelling, autonomic dysregulation, movement disorders, and atrophy and dystrophy. RSD is caused by an injury to a specific nerve or the C- and A-delta fibers that innervate the involved tissue. It is a progressive illness that spreads with time and may encompass the entire body. There is no psychological disposition to the problem, but all patients are severely depressed because of the constant pain, lack of sleep, and complete disruption of their lifestyle. The continuing pain is usually secondary to the process of central sensitization. The autonomic dysregulation has a major central nervous system component. Atrophy and dystrophy are partly due to loss of nutritive blood supply to the affected tissues. The movement disorder is partly due to deficiency of GABAergic mechanisms; the tremor is an exaggeration of the normal physiologic tremor. Treatment consists of decreasing the afferent pain, maintaining barrage from the underlying defect, and blocking the sympathetic component of the process. New developments include the use of neurotrophic factors to reverse the phenotypic changes that occur in the dorsal horn and the use of pharmacologic agents to block the activity-dependent NMDA channels that appear to be instrumental in maintaining central sensitization.

Copyright information

© Current Science Inc 2002